In contrast, interferon (IFN), a classic immunotherapy drug, has the ability to stimulate T-cell function, control the secretion of tumour products and inhibit tumour growth [25] by activation of the T-cell response against the tumour and angiogenesis inhibition [26, 27] in NETs. The gene discussed is IFNA1; the disease is neoplasm.